A detailed history of Bank Of America Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 514,543 shares of IONS stock, worth $24.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
514,543
Previous 606,298 15.13%
Holding current value
$24.8 Million
Previous $26.3 Million 6.7%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $3.34 Million - $4.38 Million
-91,755 Reduced 15.13%
514,543 $24.5 Million
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $6.36 Million - $8.1 Million
151,220 Added 33.23%
606,298 $26.3 Million
Q4 2023

Feb 14, 2024

SELL
$43.39 - $51.63 $184,016 - $218,962
-4,241 Reduced 0.92%
455,078 $23 Million
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $6.02 Million - $7.51 Million
-173,325 Reduced 27.4%
459,319 $18.8 Million
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $156,785 - $192,362
-4,669 Reduced 0.73%
632,644 $22.6 Million
Q4 2022

Feb 10, 2023

BUY
$37.12 - $46.52 $2.87 Million - $3.6 Million
77,357 Added 13.81%
637,313 $24.1 Million
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $1.78 Million - $2.36 Million
-48,596 Reduced 7.99%
559,956 $24.8 Million
Q2 2022

Aug 12, 2022

SELL
$31.71 - $43.0 $4.87 Million - $6.61 Million
-153,606 Reduced 20.15%
608,552 $22.5 Million
Q1 2022

May 16, 2022

BUY
$29.88 - $37.04 $4.46 Million - $5.53 Million
149,323 Added 24.37%
762,158 $28.2 Million
Q4 2021

Feb 08, 2022

SELL
$25.61 - $35.1 $2.49 Million - $3.41 Million
-97,282 Reduced 13.7%
612,835 $18.6 Million
Q3 2021

Nov 15, 2021

SELL
$33.54 - $40.55 $247,525 - $299,259
-7,380 Reduced 1.03%
710,117 $23.8 Million
Q2 2021

Sep 13, 2021

BUY
$34.54 - $47.25 $24.8 Million - $33.9 Million
717,497 New
717,497 $28.6 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.